|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows provided by (used in) operating activities | |||
| Net loss for the period | |||
| Adjustments for: | |||
| Amortization of intangibles and depreciation of property, plant and equipment | |||
| Elimination of Impairment loss of goodwill | |||
| Retirement benefit obligations | |||
| Share-based compensation expenses | |||
| Net gain on sale of treasury shares | |||
| Interest expenses and other financial expenses | |||
| Financial income | |||
| Effect of unwinding the discount related to advances | |||
| Increase/(decrease) in derivatives and liabilities measured at fair value | |||
| Forgiveness of conditional advances | |||
| Changes in provisions | |||
| Current and deferred taxes expenses | |||
| Other | |||
| Cash flows provided by (used in) operating activities before change in working capital requirements | |||
| Decrease / (increase) in other receivables and related accounts | |||
| Increase / (decrease) in trade payables | |||
| Increase / (decrease) in tax and social security liabilities | |||
| Changes in deferred income and other liabilities | |||
| Changes in working capital requirements | |||
| Income taxes paid | |||
| Cash flows provided by (used in) operating activities | |||
| Cash flows provided by (used in) investing activities | |||
| Acquisitions of intangible assets | |||
| Acquisitions of property, plant and equipment | |||
| Repayment / (disbursement) of the advance made to the Nice CHU | |||
| Payments for the acquisition of Prosynergia, incl. related costs, net of cash acquired | |||
| Increase in Deposits and other financial assets | |||
| Advances reimbursed by / (made to) CROs | |||
| Increase in deposits | |||
| Decrease in deposits | |||
| Interest received | |||
| Cash flows provided by (used in) investing activities | |||
| Cash flows provided by (used in) financing activities | |||
| Transaction costs related to capital increase | |||
| Net proceeds from non-convertible bond loans | |||
| Repayments of non-convertible bond loans | |||
| Net proceeds from convertible loan notes | |||
| Repayment of PGE | |||
| Repayments of conditional advances | |||
| Payments of the lease liabilities | |||
| Net proceeds from sale of treasury shares | |||
| Interest paid | |||
| Exercise of warrants | |||
| Other | |||
| Cash flows provided by (used in) financing activities | |||
| Effect of movements in exchange rates on cash held | |||
| Revaluation of cash equivalents measured at fair value | |||
| Increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents at the beginning of the year | |||
| Cash and cash equivalents at the end of the year |
Loading...
